Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing.

Angiogenesis is an essential component of normal wound repair, yet the primary mediators of wound angiogenesis have not been well described. The current study characterizes the contribution of vascular endothelial cell growth factor (VEGF) to the angiogenic environment of human surgical wounds. Surgical wound fluid samples (n = 70) were collected daily for up to 7 postoperative days (POD) from 14 patients undergoing mastectomy or neck dissection. VEGF levels in surgical wound fluid were lowest on POD 0, approximating values of serum, but increased steadily through POD 7. An opposite pattern was noted for basic fibroblast growth factor-2. Fibroblast growth factor-2, which has been previously described as a wound angiogenic factor, exhibited highest levels at POD 0, declining to near serum levels by POD 3. Surgical wound fluid form all time points stimulated marked endothelial cell chemotaxis and induced a brisk neovascular response in the rat corneal micropocket angiogenesis assay. Antibody neutralization of VEGF did not affect the in vitro chemotactic or the in vivo angiogenic activity early wound samples (POD 0). In contrast, VEGF neutralization significantly attenuated both chemotactic activity (mean decrease 76 +/- 13%, P < 0.01) and angiogenic activity (5 of 5 samples affected) of later wound samples (POD 3 and 6). The results suggest a model of wound angiogenesis in which an initial angiogenic stimulus is supplied by fibroblast growth factor-2, followed by a subsequent and more prolonged angiogenic stimulus mediated by VEGF.

[1]  R. Nicosia,et al.  Endogenous regulation of angiogenesis in the rat aorta model. Role of vascular endothelial growth factor. , 1997, The American journal of pathology.

[2]  Paul Martin,et al.  Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.

[3]  H. Dvorak,et al.  Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin. , 1997, The Journal of investigative dermatology.

[4]  R. Gamelli,et al.  Thrombospondin 1 synthesis and function in wound repair. , 1996, The American journal of pathology.

[5]  R. Gamelli,et al.  Basic fibroblast growth factor mediates angiogenic activity in early surgical wounds. , 1996, Surgery.

[6]  V. V. van Hinsbergh,et al.  Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity , 1996, The Journal of cell biology.

[7]  J. Isner,et al.  Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. , 1995, Circulation.

[8]  L. Crofford,et al.  Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin‐1: a potential mechanism for inflammatory angiogenesis , 1995, FEBS letters.

[9]  J. Erusalimsky,et al.  Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. , 1995, Circulation.

[10]  M. Longaker,et al.  Regulation of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes. , 1995, The Journal of Biological Chemistry.

[11]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.

[12]  N. Olsen,et al.  Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue , 1994, The Journal of experimental medicine.

[13]  P. Polverini,et al.  Downregulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis. , 1994, Journal of vascular research.

[14]  M. Reed,et al.  Differential expression of SPARC and thrombospondin 1 in wound repair: immunolocalization and in situ hybridization. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[15]  R. Nicosia,et al.  Angiogenic role of endogenous basic fibroblast growth factor released by rat aorta after injury. , 1993, The American journal of pathology.

[16]  F. Grinnell,et al.  Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. , 1993, The Journal of investigative dermatology.

[17]  M. Benezra,et al.  Thrombin-induced release of active basic fibroblast growth factor-heparan sulfate complexes from subendothelial extracellular matrix. , 1993, Blood.

[18]  Bing Li,et al.  Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo , 1993, Nature.

[19]  H. Dvorak,et al.  Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing , 1992, The Journal of experimental medicine.

[20]  N. Ferrara,et al.  Molecular and biological properties of the vascular endothelial growth factor family of proteins. , 1992, Endocrine reviews.

[21]  H. Dvorak,et al.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. , 1992, Molecular biology of the cell.

[22]  E. Eriksson,et al.  Healing of partial thickness porcine skin wounds in a liquid environment. , 1992, The Journal of surgical research.

[23]  R. Kirsner,et al.  Human wound fluid from acute wounds stimulates fibroblast and endothelial cell growth. , 1991, Journal of the American Academy of Dermatology.

[24]  D. Connolly,et al.  Effects of a variety of cytokines and inducing agents on vascular permeability factor mRNA levels in U937 cells. , 1991, Biochemical and biophysical research communications.

[25]  P. Mcneil,et al.  Basic fibroblast growth factor is efficiently released from a cytolsolic storage site through plasma membrane disruptions of endothelial cells , 1991, Journal of cellular physiology.

[26]  D. Connolly,et al.  Specific binding of vascular permeability factor to endothelial cells. , 1991, Biochemical and biophysical research communications.

[27]  C. Cordon-Cardo,et al.  Expression of basic fibroblast growth factor in normal human tissues. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[28]  H. Dvorak,et al.  Fibrinogen influx and accumulation of cross-linked fibrin in healing wounds and in tumor stroma. , 1988, The American journal of pathology.

[29]  M. Klagsbrun,et al.  Modulation of Wound Repair by Members of the Fibroblast Growth Factor Family , 1988 .

[30]  Jon R. Cohen.  The Molecular and Cellular Biology of Wound Repair , 1997, Springer US.

[31]  H. Dvorak,et al.  A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. , 1986, Cancer research.

[32]  P. Polverini,et al.  Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. , 1984, Laboratory investigation; a journal of technical methods and pathology.

[33]  T. K. Hunt,et al.  A quantitative in vitro study of fibroblast and endothelial cell migration in response to serum and wound fluid. , 1983, The Journal of surgical research.

[34]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[35]  T. K. Hunt,et al.  Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. , 1981, Surgery.

[36]  T. K. Hunt,et al.  Respiratory gas tensions and pH in healing wounds. , 1967, American journal of surgery.

[37]  J A SCHILLING,et al.  Studies of fibroplasia in wound healing. , 1953, Surgery, gynecology & obstetrics.